chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Numbness could not feel my body; Numbness could not feel my body; stomach upset; Mild headache; intense congestion (nasal); Out of body experience; tingling in leg and feet; This is a spontaneous report from a contactable patient. A 63-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot Number: EN6199) via an unspecified route of administration and anatomical site on 06Mar2021 at 08:30 AM (at the age of 63-year-old) as unknown, single dose for COVID-19 immunisation. Medical history included intense numbness started from last 1980s and 1990s with no concrete diagnosis and tested for multiple sclerosis (MS) which got better after a few years. The patient reported allergic to household cleaners, perfumes, sanitizing agents. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The vaccine was administered in a hospital. The patient did not receive any other vaccine within four weeks prior to the vaccination or other concomitant medications in two weeks. On 06Mar2021 at 08:30 AM, patient had numbness and she could not feel her body. When walking, she felt like she was having an out of body experience. She also had mild stomach upset (still after 10 days), mild headache and then intense congestion (nasal) day after. She still had mild numbness and tingling in legs and feet in Mar2021. No therapeutic measures were taken for the reported events. The clinical outcome of the events numbness, headache, nasal congestion and tingling in leg was recovering at the time of this report. The outcome of event stomach upset was not recovered.  No follow-up attempts are needed. No further information is expected
I'm having chills,on and off today; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (I'm having chills,on and off today) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 043B21A and 050E21A) for COVID-19 vaccination.     No medical history was provided by reporter.  Concomitant products included HYDROCHLOROTHIAZIDE, VALSARTAN (VALSARTAN HCTZ) for Blood pressure, PIOGLITAZONE HYDROCHLORIDE (ACTOS), ACETYLSALICYLIC ACID (BABY ASPIRIN), GLIMEPIRIDE, SIMVASTATIN, OMEPRAZOLE and VITAMINS NOS for an unknown indication.   On 18-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Sep-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-Sep-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced CHILLS (I'm having chills,on and off today). At the time of the report, CHILLS (I'm having chills,on and off today) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment medications were provided.    Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 16-Sep-2021: Follow up received on 16 Sep 2021 contains no new information.
Swollen under eyes and pressure in eyes lids from swelling; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the left arm on an unknown date in Apr2021 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient did not receive any concomitant medications. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021 at 07:45, the patient experienced swollen under eyes and pressure in eyes lids from swelling. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event swollen under eyes and pressure in eyes lids from swelling was recovered on an unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.
This spontaneous report as received from a registered nurse refers to a 2 year old patient of unknown gender. The patient's relevant medical history, concurrent conditions, concomitant medications, drug reactions or allergies were not reported. On 06-SEP-2017, the patient was vaccinated with improperly stored VAQTA (dosing details were not reported) (lot # N017094, expiry date: 31-AUG-2018) for prophylaxis. No adverse effects were reported. Temperature excursion was from 0 degree Celsius (C) to 1 degree C (0.8 degree C) for 52 minutes. The previous temperature excursion was reported as from 9 degree C to 25 degree C (10.9 degree C) for 3 hours 17 minutes. The call was because of a data logger. No product quality complaint involved. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1709USA007011: US-009507513-1709USA007012: US-009507513-1709USA007013: US-009507513-1709USA007014: US-009507513-1709USA000054.
Patient was given a Monovalent booster instead of a Bivalent booster. Patient has been informed of the immunization error. Patient reports no adverse reaction to the vaccine she received on 9/16/22.
Patient states she received a flu shot and the next day woke up with a rash on her body covering her head, back, legs, abdomen, hands and feet. She went to ER at hospital and received a sternal shot. Doctor told her she was allergic to vaccine and not to take the shot again.
faint; pain in joints; light headness; swollen painful lymphnodes; swollen lymph node; fever; fatigued; headache; This is a spontaneous report from a contactable consumer (patient). A 51-year-old patient of an unspecified gender received bnt162b2 (BNT162B2) dose 2 via an unspecified route of administration administered in left arm on 20Mar202114:20 (Lot Number: EP7534) as single dose for COVID-19 immunisation. Medical history included ulceritive colitis from 1996 and ongoing, fibromyalgia from 2010 and ongoing, premenstrual dysphoric disorder from 2002 and ongoing, spinal stenosis from 2011 and ongoing. Concomitant medications included trazodone taken for sleep from Feb2021 and ongoing; bupropion hydrochloride (WELLBUTRIN) taken for disturbance from 16Feb2021; cyclobenzaprine taken for muscle spasms from 2016 and ongoing; suvorexant (BELSOMRA) taken for sleep deficit from 2018 and ongoing. The patient previously took first dose of BNT162B2 on 27Feb2021 (lot# EN6203) via intramuscular in left upper arm for COVID-19 immunisation and experienced events extreme fatigue swollen lymph node. COVID virus tests were negative on 07Jan2021 and 15Jan2021. The patient experienced fever and headaches on 21Mar2021. The patient had swollen, painful lymph nodes, and pain in joint and fatigue on an unspecified date. The patient got faint every time stand up. The patient experienced lightheadedness regularly but not every time stand up. No treatment was received for events fever, headache, fatigued. The outcome of events fever was recovered in Mar2021, outcome of event headache was recovering, outcome of other was unknown.
This spontaneous report as received from a healthcare worker refers to a patient of unspecified age and gender. No current or historical conditions were reported. On 01-DEC-2014 the patient was vaccinated with the first dose of ROTATEQ (lot # K005394; expiration date: 23-FEB-2016, dosage information was not provided) orally, which was improperly stored. There were no concomitant medications reported. No adverse effect reported. There was no product quality complaint (PQC) involved. The outcome was unknown. This is one of several reports received from the same reporter. Additional information is not expected because the reporter had no further information available.
A report had been received from a literature source via regulatory authority, vaccine adverse event reporting system (VAERS) concerning an adult female subject he had been receiving FLUMIST. FLUMIST started on an unknown date. There was one report of malaise after receiving QLAV3 during pregnancy. The outcome of the event of malaise and pregnant patient received LAIV3 is unknown. The reporter's description of the event(s) was as follows: There was one report of non-serous malaise after receive QLAIV3 during pregnancy. The report was considered to be non-serious. Based on the information in this report, and awaiting the reporter's assessment, the company physician considered the causality between the event malaise with the suspect drug of FLUMIST to be related.
pt recv vax 14AUG96 & pt exp immed localized rxn w/hives/urticaria @ the inj site;several hr later, pt exp itching;tx w/DPH & recovered;
Irregular menstrual bleeding. Period-like bleeding beginning on day 19 of cycle (2 days post booster administration) despite no history of breakthrough bleeding on current contraception.  Had same issue after second Pfizer dose in April, which led to heavy bleeding and labor-like cramps. I also currently have redness, itchiness, and swelling at the injection site, which began yesterday, two days after I received the injection.
w/in approx 5 mins p/shots c/o dizziness & problems catching breath.  No apparent resp distress-R20; collapsed & became unconscious; VS remained WNL; 911 called; pt very unsteady on feet; anxiety react;
Numbness facial; Pain in arm; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (Numbness facial) and PAIN IN EXTREMITY (Pain in arm) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039k20a and 010mz0a) for COVID-19 vaccination.     Concurrent medical conditions included Food allergy (Shrimp).   On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Jan-2021, the patient experienced HYPOAESTHESIA (Numbness facial) and PAIN IN EXTREMITY (Pain in arm). On 22-Jan-2021, HYPOAESTHESIA (Numbness facial) had resolved. At the time of the report, PAIN IN EXTREMITY (Pain in arm) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Concomitant medications were reported as none.  The patient reported her cheek numbness was gone within an hour or two but every now and then over the next week, it would feel numb again like she had Novocain. The patient also reported she had her second dose of vaccine and her cheek never went numb. She reported she had a sore arm with both shots.   No treatment information was provided.  The reporter did not provide the causality assessment for the event with regards to mRNA-1273.   Most recent FOLLOW-UP information incorporated above includes: On 21-May-2021: Follow up report included: Allergy, adverse event start date and stop date, new Dose 1 event, vaccine information for Dose 1 and Dose 2 and Dose 2 event.
10 days after my second shot I developed Shingles.   It could be a coincidence, but reporting it here just in case.  I'm taking Valacyclovir and advil.   Symptoms are moderate.
Some arm soreness, redness, and warmth at injection site by next day (2/27/21).  Then areas of redness began to appear at other locations on the body and allergist put patient on antihistamine and prednisone.  Symptoms have been increasing even while on the antihistamine and prednisone.  On 3/5/21 when this report was made she reports continued pain at injection site, rashes moving from one body area to another, overall arthralgia, fatigue, tingling in hand, and dizziness.   Temperature and heart rate normal and blood pressure low normal on 3/5/21.
INTESTINAL OBSTRUCTION; Information was downloaded from database (8-99216-008L).  This spontaneous report was received from a physician and refers to a 2 month old female patient. The patient's concurrent conditions, medical history and concomitant therapies were unknown.  On 30-APR-1999, the patient was vaccinated with hepatitis b vaccine (recombinant)(RECOMBIVAX HB) lot # reporter as "0602" (dose, frequency, vaccination site, route and indication were not provided).   On 27-MAY-1999, the patient was vaccinated with other suspect therapies that  included hib conj vaccine (unspecified carrier)(HIB-TITER ) injection dose duration: 1 doses, interval unit: day, intramuscularly, batch#402203A, for immunisation, diphtheria toxoid, pertussis acellular biken vaccine, tetanus toxoid(TRIPEDIA) batch # 0089570 (dose, frequency, vaccination site, route and indication were not provided), polio vaccine inactivated (unspecified) (POLIO VACCINE "PASTEUR") batch # M1295, (dose, frequency, vaccination site, route and indication were not provided) and rotavirus g1 g2 g3 g4 reassortant vaccine live (human-rhesus)(ROTASHIELD) oral solution, batch# 4988055 (dose, frequency, vaccination site, route and indication were not provided).  On 30-MAY-1999, the patient experienced intestinal obstruction which caused hospitalization approximately in 1999. At the time of reporting, the patient had recovered from intestinal obstruction on an unspecified date. The reporter did not provide a causality assessment between the vaccines and intestinal obstruction.  Lot number 0602 is an invalid lot number for hepatitis b vaccine (recombinant).  The Agency considered intestinal obstruction to be medically significant.
Hep A  19 and older given to patient age 18 years of age and 9 months.
Patient says to be having inflammation and pain in her left arm - reported for first time 5/14/2018.
S: 41 yo female c/o B/L arm redness from upper arm to finger tips, dizziness, mild throat tightness and facial flushing after 16:10 after Pfizer vaccine that was given at 16:10. First dose of vaccine. No SOB. O: Pt flushed, arms reddened and feeling uneasy. B/P 130/100, Pulse 98. RA STATS 99%. RR 16. Lungs CTA. Benadryl 25 mg PO at 16:29, water and reassurance. B/P at 16:41 126/82, Pulse 94, SATS 100%, Lungs clear, B/L arms normal color. Hands remained chapped and reddened (too much hand washing per patient). A:  Mild allergic reaction to Pfizer vaccine, first dose. P: 16:56, patient improved, refused further care, refusal form signed and instructions given for post care and worsening symptoms.  Pt discharged to home via W/C to care. Instructed to F/U as noted.
1255  states that  feels palpitations ,  tingling , shaking hands and light headed . VS  BP 142/78,  HR 108, R 18  SPO2 99% on room air. 1306 : Denies  palpitations and shaking hand,  BP 138/72 , HR 80 , Spo2  100 on room air,  R 17 1315 ; Denies any of the symptoms. 1330: check out  vitals at the time of check out  VS  BP 136/72,  HR 72, R 17,   SPO2 99% on room air.
Info has been received regarding a case in litigation from a physician concerning a pt who was vaccinated with MMRII and developed Graves Disease or sub-acute thyroiditis post/vax. It was unknown whether the pt sought medical attention. It was noted that the physician reported, "the pt was not vaccinated in his office, as no adverse event". The physician reported he has no other info on the pt. There was no product quality complaint reported. No additional info has been requested.
administration of expired Moderna vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administration of expired Moderna vaccine) in a 77-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (administration of expired Moderna vaccine). On 29-Nov-2021, EXPIRED PRODUCT ADMINISTERED (administration of expired Moderna vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication of the patient was not reported.   No treatment was given to the patient.   The vaccines were stored in freezer, were taken out one to two vials and placed in fridge each day as needed.
Dizziness, sweats, fever (not sure how high - was at work) off and on for 4 1/2 hours.
Red itchy, hives,  and swelling forearms on left and right side starting just before 4 hours after vaccination. Slight sore throat pain about 4 and a half hours after and last about a half hour. Took two benadryl, feel better now. :)
Shortness breath nodule on lung hospitalized for 4 days hypodox on oxygen sent home with oxygen at home,6 days later blood clots DVT hospitalized again had embolism in lungs,week to see specialized in the health systems , 1. O thx for pulmonisty, then 3 more months have to see vascular dr. Because no information on why my leg was huge for3 months finally ultrasound for blood flow block iliac vein one exploratory catheter to see if unblock then surgery to place venous stents all because I think  health system set up terrible to see providers stupid call centers surgery place stents July 26 2021
Pain and soreness at the injection site began the first day after vaccination, which gradually escalated. Chills and fever began roughly 31 hours after vaccination, which reached 101.5 F within 2 hours. I took 200mg Advil to manage the fever and discomfort and went to bed. I ran a low grade fever of roughly 100 F for most of the third day, and took another 200mg Advil at one point. All symptoms disappeared by the fourth day.
This was her 2nd vaccine.  I took her to grocery store that day and she seemed fine.  The vaccine seems to have triggered escalated symptons of dimensia - halluciantion, confusion, suspicison of friends, neighbors, family.  was found wandering outside of her apartment building at night and taken to hospital.  We had seen the patient 2 days before and my husband had talked with her on 3/12 She was a bit confused but not too bad.  certainly no suspcision of family at that time.  Concern that vacinne may have triggered the event/
severe, chronic autoimmune problems throughout life;tx w/steroids, ATB & surgery;ASA now;60 day follow-up states the pt still has severe pain and weakness resemblin flu-like symptoms.
Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 02-Apr-2022; Received its 30-days Exp date; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received its 30-days Exp date) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 02-Apr-2022) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Apr-2022 at 10:04 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 02-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received its 30-days Exp date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 02-Apr-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Received its 30-days Exp date) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 02-Apr-2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.    Concomitant medication of the patient was not reported. Patient received booster vaccine past its 30 day expiry date.This vaccine was administered up until its manufacturing expiry date of 04-Apr-2022. Reporter no longer possess this lot number. On 02-Apr-2022, the patient took the second booster dose of the vaccine. No treatment information was provided by the reporter.
Day of injection (29th), I had injection site soreness by the evening. Took a dose of Tylenol 500 mg x 2 tablets. Following day (30th), I had the following: Overall muscle soreness; Joint pain in neck, lower back, hips, and knees; Chills; Low grade fever to 101F; Injection site pain. Continued Tylenol throughout the day. added 1 dose ibuprofen 200mg x 2 tablets in the evening. Following day (31st), I only had headache, lasted all day. Took only 1 dose of ibuprofen 200mg x 2 tablets in the evening. Following day (Apr 1st), No more issues.
Some pretty significant side effects; This spontaneous case was reported by a health care professional and describes the occurrence of VACCINATION COMPLICATION (Some pretty significant side effects) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for an unknown indication.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Some pretty significant side effects). At the time of the report, VACCINATION COMPLICATION (Some pretty significant side effects) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided by the reporter. No treatment information was provided by the reporter It was reported that the patient did not get the second dose and wanted to get a 1/2 dose instead.
Attendee received booster dose Pfizer vaccine at 11:33 am PDT in the Left arm.  Lot# FK9894. Attendee was directed to observation area.   At 11:57 attendee voiced complaints of Nausea. Attendee's respirations were not tachypneic or dyspneic. Attendee's skin was warm and dry. Water given.  HR:  83   BP: 110/55    RR:   15   O2Sat%:  97      12:06 - Attendee stated she felt a little better.   HR:  85   BP:  N/A   RR:   14   O2Sat%:  99  12:10 Attendee report that nausea is almost gone.  HR:  89   BP:  120/78   RR:   16   O2Sat%:  99  12:18 Denies nausea and/or other complaints- skin warm and dry.   HR:  79   BP:  122/78   RR:   20   O2Sat%:  99   Temp:  96.7  12:19 - Care Practitioner educated on home discharge/adverse reaction instructions and attendee was discharged to home.   Attendee did not have any reported escalation of symptoms and was able to walk out of clinic independently.  Attendee was retained for a longer observation time to make sure that it was safe for them to leave.